DocGo Inc. (DCGO) vs Grace Therapeutics, Inc. (GRCE)

A side-by-side comparison of DocGo Inc. and Grace Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
DocGo Inc. logo
DCGO
DocGo Inc.
$36M
$0.36HealthcareDelayed quote: Oct 6, 2026, 2:14 PM EDT
Grace Therapeutics, Inc. logo
GRCE
Grace Therapeutics, Inc.
$35M
$2.12HealthcareDelayed quote: Oct 6, 2026, 2:13 PM EDT

Total return — DCGO vs GRCE

growth of $100 · dividends reinvested · last 2y
DCGO -89.0% (-66.8%/yr)GRCE -31.6% (-17.3%/yr)GRCE compounded faster over this window
Log scale — wide-divergence pair
101001kStart $10020252026$11$68
DCGO GRCE

DCGO vs GRCE: by the numbers

  • •DCGO is the larger company ($36M vs $35M market cap).
  • •Both run net losses; GRCE's is the smaller (0.00% vs -65.29% net margin).

Metrics side by side

Valuation

MetricDCGOGRCE
P/S ratio0.12N/A
P/B ratio0.300.72

Profitability

MetricDCGOGRCE
Gross margin30.12%0.00%
Operating margin-27.67%0.00%
Net margin-65.29%0.00%
ROE-161.63%-44.50%
ROIC-89.44%-52.61%

Growth (annualized)

MetricDCGOGRCE
Revenue CAGR (5Y)11.63%N/A
Total return CAGR (5Y)-48.40%N/A

Go deeper

Full DCGO analysisFull GRCE analysisInteractive comparison tool

Dig into the metrics

DocGo ROEGrace Therapeutics ROEDocGo operating marginGrace Therapeutics operating marginDocGo revenue growthGrace Therapeutics revenue growthDocGo free cash flowGrace Therapeutics free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.